This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Atlantis Healthcare Webinar Addresses Paradigm Shift In Cancer Care: Improving Oncology Outcomes With Intelligent Adherence

SUMMIT, N.J., Oct. 11, 2013 /PRNewswire/ -- Atlantis Healthcare, global leaders in treatment adherence programs, will sponsor a multi-stakeholder webinar on Tuesday, October 15 th to examine challenges, opportunities and implications surrounding the shift to patient self-administered oral oncology treatments.

"All sectors of the oncology healthcare community must develop new strategies around treatment adherence to accommodate the change in responsibility of care from hospital staff to patient, from IV therapies to oral oncolytics," said Aunia Grogan, CEO, Atlantis Healthcare.  "We've gathered experts from pharma, nursing and health psychology to provide valuable insights for all stakeholders involved in this evolving area of oncology disease management."

Webinar details:

  • Tuesday, October 15 London: 3 pm; Madrid/ Paris: 4 pm; New York: 10 am; San Francisco: 7 am
  • Duration: One hour, including Q&A

Speakers:

  • Steven Cadwallader, Pierre-Fabre Marketing Manager (UK) will explain the steps that pharma can take to ensure adherence
  • Kathy Leifeste, experienced oncology nurse educator from the Overlook Medical Center ( Summit, NJ) will share front line case studies that illustrate the right approach to help patients manage their treatments
  • Lina Eliasson, PhD., accomplished health psychology expert specializing in oncology, will discuss the proven techniques for predicting and addressing nonadherence along with effective techniques to drive behavior change

All attendees will be able to access a comprehensive White Paper addressing the changing therapeutic area of oncology, including interviews with patients and leading researchers.

To participate in the free webinar, register online

For more information on Atlantis Healthcare's approach to treatment nonadherence, visit www.atlantishealthcare.com/us.

About Atlantis HealthcareEstablished in 1993, Atlantis Healthcare creates and executes tailored patient support programs and personalized interventions to address treatment adherence across a wide range of chronic and acute diseases, worldwide.  Led by one of the world's largest health psychology teams, our patient-centric approach is designed to improve health outcomes and deliver optimal value for all healthcare stakeholders. 

SOURCE Atlantis Healthcare

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs